Nille Klæbel
Chief Executive Officer @ Atlas Antibodies
Copenhagen, Denmark
Nille Klæbel is a pre-seed investor at Atlas Antibodies in Copenhagen focused on Health Care. Nille Klæbel is the Chief Executive Officer at Atlas Antibodies. Nille Klæbel attended IMD.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Nille Klæbel invests in
Stages Nille Klæbel invests in
Countries Nille Klæbel invests in
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NordInsight
|
NordInsight is a browser-based implant database, you can reduce the risk to MRI scan patients. Scan confidently alongside renowned medical facilities throughout the globe. | $173.8K / Pre-Seed / Aug 25, 2023 |
Co-Investors
About Atlas Antibodies
Atlas Antibodies develops, produces, and globally markets and sells advanced reagents for biomedical research. The company originates from the Human Protein Atlas project and was founded in 2006 by researchers at the Royal Institute of Technology (KTH) and Uppsala University. Atlas Antibodies is based in Stockholm and is majority-owned by PatriciaIndustries, a part of Investor AB.
Atlas Antibodies Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Nille Klæbel
Chief Executive Officer
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Nille Klæbel invest in?
Nille Klæbel invests primarily in Health Care startups, most often at Pre-Seed stage. Most of the 1 investments tracked by Shizune back companies in Denmark. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Nille Klæbel last invest?
The most recent investment recorded for Nille Klæbel closed in Aug 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
